Palo Alto Networks holds the cleaner structural position, with growth as the main driver and valuation adding further support. BioMarin Pharmaceutical still has the edge on valuation, which keeps the comparison from looking entirely one-sided. The market setup broadly confirms the structural lead — Palo Alto Networks holds the more constructive position. That puts structure and market broadly in agreement — Palo Alto Networks's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.
The clearest separation starts in growth, but stability adds another real layer to the result. The overall score gap is 10 points in favour of Palo Alto Networks, Inc..
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
A solid similarity means the pair shares a clearly comparable long-term financial profile, even if individual dimensions still differ.
The clearest structural overlap shows up in investment intensity and recent revenue growth.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Palo Alto Networks, Inc. still looks cheaper, even though BioMarin Pharmaceutical Inc. remains structurally stronger.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where BMRN and PANW each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
Earnings growth is one contributing factor within the growth lead.
Absolute pricing still looks more supportive for BioMarin Pharmaceutical, with a forward P/E that is 53 turns lower there.
Growth settles the comparison, while pricing and valuation keep the broader setup from looking fully aligned.
Break down the BMRN vs PANW comparison across all dimensions with the full interactive tool.
Explore how BMRN and PANW each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.